Skip to main content
ConductScienceScienceDex

Babu, Suma

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #73
Unclaimed recordClaim profile
  • Top 1% Funded
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$21.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#73
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Babu, Suma. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Babu, Suma as a PI. Multi-PI records show the full award amount for context.

  • 1U01NS136020-01U01Contact PI
    Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
    Massachusetts General Hospital · Neurology (investigator's affiliation)
    $11.2M
    award amount
  • 1U01NS136021-01U01Contact PI
    An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine
    Massachusetts General Hospital · Neurology (topic-inferred)
    $10.1M
    award amount

Award organization

Organizations that administered FY2023 awards listing Babu, Suma as a PI.

FY2023 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2022
    First NIH Award
    Massachusetts General Hospital
  2. 2022
    $500K Cumulative Funding
  3. 2022
    $1M Cumulative Funding
  4. 2022
    $2M Cumulative Funding
  5. 2022
    $5M Cumulative Funding
  6. 2022
    $10M Cumulative Funding
  7. 2022
    Entered Top 50% Nationally
    Ranked #96
  8. 2022
    Entered Top 25% Nationally
    Ranked #96
  9. 2022
    Entered Top 10% Nationally
    Ranked #96
  10. 2022
    Entered Top 5% Nationally
    Ranked #96
  11. 2022
    Entered Top 1% Nationally
    Ranked #96
  12. 2023
    $25M Cumulative Funding

Explore further

Find collaborators for Babu, Suma

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →